Caroline Popper founded Popper and Company with Ken Walz more than 15 years ago to address inefficiencies in health care by helping life science companies develop and commercialize new technology. Today, the members of their team leverage their extensive knowledge of the tools and trends shaping all aspects of health care and its participants. A particular focus of the firm is the information (from diagnostics, imaging, sensors and all data sources) that contributes to efficiency, and the companies and investors that build business in this area.

Caroline has more than 25 years of hands-on operating experience within health care companies. She did not set out to be a businessperson. Rather, she became a physician (University of the Witwatersrand, South Africa) and an internist and pathologist (The Johns Hopkins University). Most impactful was her training in health policy and health economics at the Johns Hopkins Bloomberg School of Public Health.

Caroline has managed a wide spectrum of diagnostics, device and drug discovery businesses in both Fortune 500 and start-up settings at Becton Dickinson, bioMerieux and MDS, among other firms. Now, at her firm, she combines those experiences with her clinical experience to help clients interpret relevant market forces, develop strategies and create partnerships to thrive in the global changing health care landscape.